Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity | Citedby Results | Cancer Research Communications | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity

Cancer Research Communications (2022) 2 (11): 1334–1343.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats

Niloufar Mansooralavi
Eugen V Khomula
Jon D Levine

Molecular Pain (2023) 19